Vanessa Ames Wittman
Known title: DirectorCIK: 0001229265
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
BKNG Analysts See Upside; Agoda Partners with Emerging Travel Group. Wall Street analysts maintain a positive outlook on Booking Holdings, with an average price target of $233.83. The company also announced a strategic partnership between Agoda and Emerging Travel Group to expand its presence in Asian markets. These developments occur while the stock trades near its 52-week range, reflecting mixed market sentiment.
Transaction History
| OSCR | ▼ Sell | Open Market | 25,000 | $806K | 9/18/2026 | View on chart |
| BKNG | ▼ Sell | Open Market | 375 | $79K | 8/17/2026 | View on chart |
| BKNG | ▼ Sell | Open Market | 1,125 | $216K | 7/28/2026 | View on chart |
| OSCR | ▲ Buy | Grant | 8,475 | $0 | 6/4/2026 | View on chart |
| BKNG | ▲ Buy | Grant | 1,583 | $0 | 5/30/2026 | View on chart |
| BKNG | ▼ Sell | Open Market | 1,125 | $216K | 4/17/2026 | View on chart |
| BKNG | ▼ Sell | Open Market | 15 | $78K | 1/15/2026 | View on chart |
| BKNG | ▼ Sell | Open Market | 15 | $80K | 12/15/2025 | View on chart |
| BKNG | ▼ Sell | Open Market | 15 | $75K | 11/17/2025 | View on chart |
| BKNG | ▼ Sell | Open Market | 15 | $79K | 10/15/2025 | View on chart |
| BKNG | ▼ Sell | Open Market | 15 | $83K | 9/15/2025 | View on chart |
| OSCR | ▲ Buy | Grant | 14,134 | $0 | 6/4/2025 | View on chart |
| BKNG | ▲ Buy | Grant | 48 | $0 | 5/30/2025 | View on chart |
| OSCR | ▲ Buy | Grant | 8,974 | $0 | 6/6/2024 | View on chart |
| BKNG | ▲ Buy | Grant | 71 | $0 | 5/30/2024 | View on chart |
| OSCR | ▲ Buy | Grant | 19,751 | $0 | 6/8/2023 | View on chart |
| BKNG | ▲ Buy | Grant | 102 | $0 | 5/30/2023 | View on chart |
| OSCR | ▲ Buy | Grant | 35,787 | $0 | 6/9/2022 | View on chart |
| BKNG | ▲ Buy | Grant | 117 | $0 | 5/30/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Oscar Health Analyst Target Rises to $34.19
Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.
Oscar Health Analyst Target Rises to $34.19. Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.